Overview

• Final subscription reached 82.61 times overall, with QIBs at 35.86x, NIIs at 209.42x, and retail at about 55x.
• The basis of allotment is expected to be finalised on September 4, followed by refunds and demat credits by September 8 and a tentative BSE/NSE listing on September 9.
• Grey‑market quotes have cooled to roughly Rs 8–9 per share, implying an estimated 6–7% premium to the Rs 126 upper issue price.
• The Rs 126 crore offer was an all‑fresh issue of 1 crore shares in a price band of Rs 120–126 with a minimum lot of 119 shares.
• The company plans to deploy about Rs 70 crore for a SteriPort line and Rs 30.13 crore for a new small‑volume parenteral line at its Gujarat facilities.